TRANSGLUTAMINASE-HEMMER

European patent · EP4192813 · In force

Register entry

Publication number
EP4192813
Application number
EP22741487
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 30, 2022
Published
Jun 14, 2023
Granted
Aug 14, 2024
Protection ends at the latest
Jun 29, 2042
Next annual fee due
Jun 30, 2027
IPC classes
C07D 213/75 (2006.01)
C07D 401/12 (2006.01)
C07D 405/12 (2006.01)
C07D 409/12 (2006.01)
C07D 413/12 (2006.01)
C07D 417/12 (2006.01)
C07D 453/02 (2006.01)
C07D 513/04 (2006.01)
C07D 471/04 (2006.01)
A61K 31/443 (2006.01)
A61P 37/02 (2006.01)
Priority
EP 21182956 30.06.2021
EP 21183316 01.07.2021
US 202163217783 P 02.07.2021
WO PCT/EP2021/086674 17.12.2021
WO PCT/EP2022/065430 07.06.2022
PCT application
PCT/EP2022/068216 30.06.2022
PCT publication
WO2023/275336 05.01.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jun 25, 2025

    Change

    Published in Swissreg on 25.06.2025

  4. Aug 14, 2024

    Granted

    Published in Swissreg on 14.08.2024

Parties

Holder

Zedira GmbH

Rösslerstrasse 83, 64293 Darmstadt, DE

Inventor

STIELER, Martin

64285 Darmstadt, DE

BÜCHOLD, Christian

61184 Karben, DE

GERLACH, Uwe

65795 Hattersheim, DE

PASTERNACK, Ralf

64347 Griesheim, DE

HILS, Martin

64295 Darmstadt, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.